SynAct Pharma AB. (SYNACT.ST) Q2 2024 Earnings

30MayConfirmed
May 22
Aug 22
Nov 22
Q2 2024
-0.91
-0.72
-0.53
-0.35

Details

Expected EPS
-0.34638324
Actual EPS
-0.69276648
Surprise EPS
-0.35
Surprise Percent
+100%

Description

SynAct Pharma AB. (SYNACT.ST) has reported earnings of -0.69276648 per share for Q2 2024.

0 Comments

Share your thoughts